Épisodes

  • Evolution and Clinical Impact of PDE5 Inhibitors

    Evolution and Clinical Impact of PDE5 Inhibitors
    Jul 25 2025

    In the intricate and occasionally humorous world of medical discoveries, phosphodiesterase type 5 (PDE5) inhibitors stand out as a particularly fortunate accident. Originally developed in the late 1980s for treating angina—a common heart condition characterized by chest pain—these compounds initially failed to significantly improve cardiac symptoms.

    Afficher plus Afficher moins
    3 min